Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial. (Q42224371)
Jump to navigation
Jump to search
scientific article published on 28 August 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial. |
scientific article published on 28 August 2013 |
Statements
1 reference
Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial (English)
Stephen E Gitelman
Peter A Gottlieb
Mark R Rigby
Eric I Felner
Steven M Willi
Lynda K Fisher
Antoinette Moran
Michael Gottschalk
Wayne V Moore
Ashley Pinckney
Lynette Keyes-Elstein
Sudeepta Aggarwal
Deborah Phippard
Peter H Sayre
Linna Ding
Jeffrey A Bluestone
Mario R Ehlers
START Study Team
28 August 2013
1 reference
1 reference